We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




First Human Implant Performed With New Open Mitral Annuloplasty Ring

By HospiMedica International staff writers
Posted on 26 Sep 2026

In mitral valve repair, clinicians aim to preserve the mitral annulus’s three-dimensional motion while providing enough support for effective remodeling. More...

Ring preferences vary between open and closed configurations, while sizing must accommodate a broad range of mitral pathology. A new device now adapts a long-standing semi-rigid annuloplasty platform to an open configuration, giving surgeons an additional option for repair.

Corcym (Milan, Italy) announced the first-in-human implant of Memo 4D Curve, a semi-rigid open-configuration annuloplasty ring for mitral valve repair, performed at UVA Health University Medical Center (Charlottesville, VA, USA). The ring extends more than 20 years of the company’s Nitinol-based Memo technology to an open configuration for surgeons who prefer an open annuloplasty. The Memo platform now encompasses both open and closed configurations.

Memo 4D Curve is designed to preserve the natural three-dimensional motion of the mitral annulus while providing the support needed to remodel it. The device is available in sizes up to 42 mm, addressing pathology from standard degenerative disease to markedly dilated annuli. The ring is FDA-cleared and commercially available in the United States.

The inaugural procedure was performed at UVA Health University Medical Center, reflecting a focus on minimally invasive and robotic approaches. Corcym will formally introduce Memo 4D Curve to the international cardiac surgery community at the EACTS Annual Meeting in October 2026, marking 20 years of the Memo platform.

“Performing the first implant of Memo 4D Curve is an exciting moment for our team. Having the Memo platform available in an open configuration gives us another option when performing mitral valve repair,” said Michael Ibrahim, MD, PhD, robotic cardiac surgery lead at UVA Health University Medical Center.

“With this milestone, the Memo platform takes another step forward, giving surgeons greater choice in mitral valve repair and reaffirming our ongoing commitment to advancing the field alongside the cardiac surgery community,” said Christian Mazzi, Chief Executive Officer of Corcym.

Related Links
Corcym
UVA Health 


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Blood Gas Analyzer
i-Check200
Radiofrequency Generator
GX1
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Visual Abstract (Andrea Farolfi et al., Journal of Nuclear Medicine, 2026. DOI: 10.2967/jnumed.126.272108)

PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI

Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. Men with persistent clinical risk factors may still require biopsy, yet standard... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: WHX returns to Dubai Exhibition Centre, Expo City, and Dubai World Trade Centre from 5–28 January 2027 (Photo courtesy of World Health Expo)

World Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition

World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000 professional visits, over 4,200 exhibitors and representatives from over... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.